Zobrazeno 1 - 10
of 5 021
pro vyhledávání: ''
Autor:
Eduard Vieta, Christopher Gaudiot, Ross J. Baldessarini, Mauricio Tohen, Yiliang Zhu, Anastasiya Nestsiarovich
Publikováno v:
European Neuropsychopharmacology. 54:75-89
Uncertainty remains regarding the relative efficacy of maintenance pharmacotherapy for bipolar disorder (BD), and available data require updating. The present systematic review and meta-analysis aims to consolidate the evidence from the highest quali
Autor:
Natalie T. Mills, Hikaru Hori, Scott R. Clark, Célia Fourrier, Bernhard T. Baune, Jennie Louise, K Oliver Schubert, Emma Sampson
Publikováno v:
European Neuropsychopharmacology. 53:34-46
Given the role of low-grade inflammation in the pathophysiology of major depressive disorder (MDD), anti-inflammatory strategies may improve treatment outcomes in some patients. However, it is controversial whether they can be used as adjunctive trea
Autor:
Esther Berrocoso, Manuel Desco, Juan Antonio Mico, Laura Perez-Caballero, M.L. Soto-Montenegro
Publikováno v:
European Neuropsychopharmacology. 51:1-6
Escitalopram is a selective serotonin reuptake inhibitor (SSRIs) antidepressant, drug that is currently used as first-line agents for the treatment of depression and it is also used in the treatment of other psychiatric disorders. The main goal of th
Publikováno v:
European Neuropsychopharmacology. 51:90-104
Daridorexant (ACT-541468) is a new dual orexin receptor antagonist being evaluated for the treatment of insomnia, which is a common comorbidity of depression and anxiety. Therefore, daridorexant is likely to be administered concomitantly with agents
Autor:
Christiane Mühle, Valery Grinevich, Johannes Kornhuber, Patrick Bach, Christian Weinland, Falk Kiefer, Bernd Lenz, Iulia Zoicas
Publikováno v:
European Neuropsychopharmacology. 51:55-67
Alcohol use disorder (AUD) is a severe illness, for which we lack sufficient mechanistic understanding. Preliminary evidence associates AUD with the oxytocin (OXT) system. Here we investigated alterations in endogenous OXT blood concentrations in pat
Publikováno v:
European Neuropsychopharmacology. 50:75-92
Considering the global increase in use of Z-drugs to treat insomnia, the study objective was to conduct a systematic review on the efficacy and safety of zopiclone to treat sleep disorders in older adults compared to other sedative-hypnotics, to plac
Autor:
Claudia da Costa Leite, Márcio Gerhardt Soeiro-de-Souza, E. Scotti-Muzzi, Fernando Fernandes, Rodrigo Machado-Vieira, R. T. De Sousa, Maria Concepcion Garcia Otaduy
Publikováno v:
European Neuropsychopharmacology. 49:93-100
The diagnosis and treatment of bipolar depression (BDep) poses complex clinical challenges for psychiatry. Proton magnetic resonance spectroscopy (1H-MRS) is a useful imaging tool for investigating in vivo levels of brain neuro-metabolites, critical
Autor:
Aranzazu Fernandez-Rivas, Nora Maria Raschle, Amy E Wells, Karen Gonzalez-Madruga, Christine M. Freitag, Réka Siklósi, Maider González de Artaza-Lavesa, Gregor Kohls, Amaia Hervás, Beate Herpertz-Dahlmann, Arne Popma, Anka Bernhard, Katharina Ackermann, Stephane A. De Brito, Graeme Fairchild, Christina Stadler, Anne Martinelli, Kerstin Konrad, Marietta Kirchner, Angeliki Konsta
Publikováno v:
European Neuropsychopharmacology, 49, 40-53. Elsevier
Bernhard, A, Kirchner, M, Martinelli, A, Ackermann, K, Kohls, G, Gonzalez-Madruga, K, Wells, A, Fernández-Rivas, A, de Artaza-Lavesa, M G, Raschle, N M, Konsta, A, Siklósi, R K, Hervás, A, Herpertz-Dahlmann, B, de Brito, S A, Popma, A, Stadler, C, Konrad, K, Fairchild, G & Freitag, C M 2021, ' Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk ', European Neuropsychopharmacology, vol. 49, pp. 40-53 . https://doi.org/10.1016/j.euroneuro.2021.03.016
Bernhard, A, Kirchner, M, Martinelli, A, Ackermann, K, Kohls, G, Gonzalez-Madruga, K, Wells, A, Fernández-Rivas, A, De Artaza-Lavesa, M G, Raschle, N M, Konsta, A, Siklósi, R, Hervás, A, Herpertz-Dahlmann, B, De Brito, S A, Popma, A, Stadler, C, Konrad, K, Fairchild, G & Freitag, C M 2021, ' Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk ', European Neuropsychopharmacology, vol. 49, pp. 40-53 . https://doi.org/10.1016/j.euroneuro.2021.03.016
Bernhard, A, Kirchner, M, Martinelli, A, Ackermann, K, Kohls, G, Gonzalez-Madruga, K, Wells, A, Fernández-Rivas, A, de Artaza-Lavesa, M G, Raschle, N M, Konsta, A, Siklósi, R K, Hervás, A, Herpertz-Dahlmann, B, de Brito, S A, Popma, A, Stadler, C, Konrad, K, Fairchild, G & Freitag, C M 2021, ' Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk ', European Neuropsychopharmacology, vol. 49, pp. 40-53 . https://doi.org/10.1016/j.euroneuro.2021.03.016
Bernhard, A, Kirchner, M, Martinelli, A, Ackermann, K, Kohls, G, Gonzalez-Madruga, K, Wells, A, Fernández-Rivas, A, De Artaza-Lavesa, M G, Raschle, N M, Konsta, A, Siklósi, R, Hervás, A, Herpertz-Dahlmann, B, De Brito, S A, Popma, A, Stadler, C, Konrad, K, Fairchild, G & Freitag, C M 2021, ' Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk ', European Neuropsychopharmacology, vol. 49, pp. 40-53 . https://doi.org/10.1016/j.euroneuro.2021.03.016
Conduct Disorder (CD) is characterized by severe aggressive and antisocial behavior. The stress hormone system has frequently been investigated as a neurobiological correlate of CD, while other interacting neuroendocrine biomarkers of sex hormone or
Autor:
Thomas Habekost, Julijana le Sommer, Birte Glenthøj, Signe Vangkilde, Bob Oranje, Birgitte Fagerlund, Jens Richardt Møllegaard Jepsen, Ann-Marie Low
Publikováno v:
European Neuropsychopharmacology. 46:83-92
Deficient information processing in ADHD theoretically results in sensory overload, which in turn may underlie its symptoms. If this sensory overload is caused by deficient filtering of environmental stimuli, then one would expect finding deficits in
Autor:
Anouk Schrantee, Liesbeth Reneman, Marco A. Bottelier, Cheima Bouziane, Hyke G. H. Tamminga, Annabeth P. Groenman, Hilde M. Geurts
Publikováno v:
European neuropsychopharmacology, 46, 1-13. Elsevier
European Neuropsychopharmacology, 46, 1-13. Elsevier
European Neuropsychopharmacology, 46, 1-13. Elsevier
Methylphenidate (MPH) is the first-choice pharmacological treatment for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. However, it is unclear whether MPH affects cognitive development, while recent (pre-) clinical s